
XWRAP® - Amniotic Membrane-derived Allograft
From Applied Biologics website: XWRAP customers have provided anecdotal evidence suggesting that XWRAP outperforms other skin substitutes currently available in the market. This superiority stems from its unique processing, dehydration, and sterilization methods. The proprietary processing of XWRAP has demonstrated superior handling and biodegradability characteristics. It exhibits a slower and more controlled breakdown, thereby offering prolonged and enhanced performance as a protective cover and wound barrier. The product undergoes natural dehydration without heat and a gentle sterilization process, which helps preserve its durability and extracellular matrix. In contrast, similar products not subjected to such sterilization tend to rapidly degrade, resulting in inferior performance compared to XWRAP. XWRAP has been selected for its exceptional performance attributes, expected to reduce product usage and enhance patient outcomes. Ongoing clinical studies on XWRAP are currently underway, with results anticipated for publication in 2025. CLICK HERE to go to the Applied Biologics web page on Active Care's website for more information.
​
If you are a Wound Care practitioner, contact us for your interest in using XWRAP. The product cannot be obtained direct from Applied Biologics. Contact Active Care if you are interested in using the product. CLICK